These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5328125)

  • 21. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
    Chin W; Lunn JS; Buxbaum J; Contacos PG
    Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
    [No Abstract]   [Full Text] [Related]  

  • 23. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria: epidemiology, pathogenesis, diagnosis, prevention, and treatment--an update.
    Ryan ET
    Curr Clin Top Infect Dis; 2001; 21():83-113. PubMed ID: 11572163
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospital and field traials of sulformethoxine with pyrimethamine against Malaysian strains of Plasmodium falciparum and P. vivax.
    Laing AB
    Med J Malaya; 1968 Sep; 23(1):5-19. PubMed ID: 4237560
    [No Abstract]   [Full Text] [Related]  

  • 26. Tetraoxanes as antimalarials: harnessing the endoperoxide.
    Fisher LC; Blackie MA
    Mini Rev Med Chem; 2014 Feb; 14(2):123-35. PubMed ID: 24456270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pharmacology of antimalarials].
    Fernex M; Leimer R
    Schweiz Rundsch Med Prax; 1986 Apr; 75(16):438-45. PubMed ID: 3518010
    [No Abstract]   [Full Text] [Related]  

  • 29. [Malaria despite chemoprophylaxis: problems for diagnosis and therapy].
    Markwalder K
    Schweiz Rundsch Med Prax; 1986 Apr; 75(16):449-53. PubMed ID: 3518011
    [No Abstract]   [Full Text] [Related]  

  • 30. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on depot antimalarials. I. The effect of a single injection of the depot antimalarial CI-501 ("Camolar") on relapsing vivax malaria acquired in New Guinea.
    Black RH; Dew BB; Hennessy WB; McMillan B; Torpy DC
    Med J Aust; 1966 Sep; 2(13):588-92. PubMed ID: 5921546
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug resistance in malaria: three cases and a review.
    Isaac-Renton JL; Koon AL; Chan RM; Chow AW; Sacks SL
    Can Med Assoc J; 1983 Sep; 129(5):454-7. PubMed ID: 6349767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea.
    Rieckmann KH
    Am J Trop Med Hyg; 1966 Nov; 15(6):833-7. PubMed ID: 5335161
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress in malaria chemotherapy. 1. Repository antimalarial drugs.
    Elslager EF
    Prog Drug Res; 1969; 13():170-216. PubMed ID: 4902378
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
    Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
    Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field trials of repository antimalarial compounds.
    Clyde DF
    J Trop Med Hyg; 1969 Apr; 72(4):81-5. PubMed ID: 4890149
    [No Abstract]   [Full Text] [Related]  

  • 37. Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity.
    Russell B; Malleret B; Suwanarusk R; Anthony C; Kanlaya S; Lau YL; Woodrow CJ; Nosten F; Renia L
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5170-4. PubMed ID: 23877705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA.
    COATNEY GR; CONTACOS PG; LUNN JS
    Am J Trop Med Hyg; 1964 May; 13():383-5. PubMed ID: 14159973
    [No Abstract]   [Full Text] [Related]  

  • 39. [The current status of the resistance of malaria pathogens to antimalarials].
    Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV
    Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimalarial drug resistance: an increasing problem.
    Peters W
    Br Med Bull; 1982 May; 38(2):187-92. PubMed ID: 7052200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.